Gene Therapy Falls Behind as Investors Chase Weight-Loss Drug Boom
22 Mar 2025
Gene therapy, once hailed as the future of medicine, is facing a decline in investor interest as pharmaceutical companies and venture capitalists pivot towards the booming market of weight-loss drugs. The shift is driven by the promise of quicker returns, broader consumer demand, and regulatory hurdles that make gene therapy...
Read More
